TrialsgrambetaRCTs are beautiful

CRASH-2

2010

Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage

In 20,211 trauma patients with significant haemorrhage, tranexamic acid within 3 hours reduced all-cause death versus placebo.

Result

Efficacy: In-hospital all-cause mortality at 4 weeksRR 0.91 · P = 0.0035

Below 1 favours tranexamic acid within 3 hours, above 1 favours placebo.

Event rates
Absolute difference
1.5 points
NNT
67

Absolute difference and NNT are derived from the event rates.

Also reported: Benefit only ≤3 h from injury.

Original publication
Subtopic
Tranexamic acid
Design
International RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
CRASH-2 Trial Collaborators. Lancet. 2010;376(9734):23-32.doi 10.1016/S0140-6736(10)60835-5

Discussion & critique

Cheap, available, time-critical; the central trauma drug since 2010.

Discussed in podcasts